Compound repurposing
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
Aranorosin (HB3768)
Description:Antibiotic with antibacterial, anticancer and antifungal activity
Purity:>95%
(S)-(+)-Ascochin (HB3702)
Description:Antibiotic with antifungal and phytotoxic activity
Purity:>98%
Aspterric acid (HB3779)
Description:Antibiotic. Pollen growth and development inhibitor.
Purity:>95%
Borrelidin (HB3810)
Description:Antibiotic. Threonyl-tRNA synthetase (THrRS) inhibitor.
Purity:>98%
Brefeldin A (BFA) (HB2949)
Description:Reversible protein transport inhibitor. Commonly used in cytokine staining. Enhances CRISPR-mediated HDR.
Purity:>98%